Novo Nordisk is facing a massive wave of generic competitors to its injectable formulations of GLP-1 agonist semaglutide, used to treat diabetes and obesity, as a key patent in India is due to expire ...

Learn prompt engineering with this practical cheat sheet that covers frameworks, techniques, and tips for producing more ...

Learn how to master Claude Design to build cohesive design systems, landing pages, and mobile prototypes without generic AI ...